Open AccessDetection of Vancomycin Resistance among Enterococcus faecalis and Staphylococcus aureus
Author(s) -
Ramya Rengaraj,
M Shanthi,
Uma Sekar,
Arunagiri Kamalanadhan
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/17552.7201
Subject(s) - teicoplanin , vancomycin , microbiology and biotechnology , staphylococcus aureus , enterococcus faecalis , linezolid , clindamycin , methicillin resistant staphylococcus aureus , enterococcus , cefoxitin , staphylococcus , antibiotics , biology , medicine , bacteria , genetics
Vancomycin remains the drug of choice for resistant gram positive infections caused by Enterococcus spp and Methicillin resistant Staphylococcus aureus (MRSA). Increased use of vancomycin has led to frank resistance and increase in MIC (MIC creep). Vancomycin intermediate Staphylococcus aureus (VISA), Vancomycin resistant Staphylococcus aureus (VRSA) & Vancomycin resistant Enterococci (VRE) are important emerging nosocomial pathogens resulting in treatment failures.